Feb 3 (Reuters)-
Wakamoto Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2015 Dec 31, 2014 Mar 31, 2016
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 8.57 8.15 11.50
(+5.1 pct) (+3.1 pct) (+7.1 pct)
Operating 221 mln 331 mln 130 mln
(-33.1 pct) (+4.9 pct) (-35.9 pct)
Recurring 280 mln 397 mln 200 mln
(-29.3 pct) (-6.1 pct) (-14.4 pct)
Net 168 mln 254 mln 110 mln
(-33.8 pct) (+4.7 pct) (+32.0 pct)
EPS 4.85 yen 7.32 yen 3.17 yen
Ann Div 3.00 yen 3.00 yen
-Q2 div NIL NIL
-Q4 div 3.00 yen 3.00 yen
NOTE - Wakamoto Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T
((Tokyo Headline News Desk +813 6441 1812))